Sandau, Ursula S.
Wiedrick, Jack T.
McFarland, Trevor J.
Galasko, Douglas R.
Fanning, Zoe
Quinn, Joseph F.
Saugstad, Julie A.
Funding for this research was provided by:
U.S. Department of Health and Human Services | NIH | National Institute on Aging (RF1AG059392)
Article History
Received: 17 August 2023
Accepted: 18 January 2024
First Online: 25 January 2024
Competing interests
: Dr. Galasko is a consultant for Biogen, Esai, GE Healthcare, Fujirebio, Generian and Amprion, and serves on a DSMB for Cognition Therapeutics. All other study authors report no conflicts of interest.